Improve documentation
Clarify guidance, examples, and onboarding materials.
Open-source ecosystem for in vitro and microphysiological systemsOpen-source resources
PhysioVerse maintains reusable resources that help contributors, users, curators, and developers apply shared practices in practical workflows.
What is maintained
Open-source resources should help people do real work: prepare data, describe systems, validate records, review submissions, search datasets, and reuse approved resources.
Contribution pathways
Contributions can be scientific, technical, documentary, or curatorial. The goal is to improve resources that are maintained and reused by the community.
Clarify guidance, examples, and onboarding materials.
Help refine metadata templates, descriptor examples, or sample record formats.
Contribute schemas, validators, catalog utilities, or workflow components.
Test resources against realistic submissions and identify gaps.
Maintenance
Resources should be versioned, documented, tested against examples, and updated when workflows or community needs change. This keeps the ecosystem useful without making resources rigid or obsolete.
Contribute
Developers, curators, users, and contributors can help improve open resources.
Standards and manufacturing partners
Connect with the organizations advancing consensus standards, validation, and regenerative manufacturing across the PhysioVerse ecosystem.
The Microphysiological and Organoid Systems Standards Development Organization (MOSSDO) is a federally funded multi-stakeholder initiative focused specifically on establishing consensus-based standards for organoids, microphysiological systems (MPS), and body-on-a-chip technologies. MOSSDO develops frameworks for reproducibility, validation, and interoperability, enabling these platforms to be more reliably adopted across research, regulatory, and translational settings. In coordination with enabling ecosystem efforts such as PhysioVerse, MOSSDO provides the standards foundation that supports data integration, comparability, and broader field-wide adoption.
The Regenerative Manufacturing Innovation Consortium (RegMIC), founded in 2014, is a national initiative that brings together stakeholders from industry, academia, and government to advance the manufacturing, scale-up, and commercialization of regenerative technologies. Through cross-sector collaboration, RegMIC addresses key challenges in translation, including process development, regulatory alignment, and the establishment of best practices across cell, tissue, and advanced in vitro systems.